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ABSTRACT 
Breast cancer is one of the most common forms of cancer occurring in females resulting in to   
high rate of mortality worldwide. Uncontrolled cell proliferation leads to cancer which may 
be attributed to genetic mutations or epigenetic alterations in the genome. Deregulations of 
epigenetic mechanisms are highly associated with cancer progression. Uncontrolled cell 
proliferation and evasion of apoptosis are important hall marks of cancer progression. Hence 
in this study we have investigated the role of sulforaphane and curcumin in the induction of 
apoptosis in metastatic adenocarcinoma MDA-MB-231 cells. As aberrant Histone 
methylation and demethylation pathways are most commonly associated with breast cancer 
progression, we have also tried to investigate the expression profile of Jmjd3, a key histone 
demethylase, at transcriptome level after treatment with of sulforaphane and curcumin for 24 
hours. This investigation also aimed at finding a correlation between Jmjd3 expression and 
induction of apoptosis in breast cancer cell line MDA-MB-231. The down regulation of anti 
apoptotic gene Bcl-2 and up regulation of pro apoptotic gene Bax along with formation of 
chromatin condensation, DNA fragmentation and DNA damage suggests that there is 
induction of apoptosis in response to the sulphoraphane and curcumin treatment for 24 hours 
at their corresponding IC50 values. From all these investigations we can presume that may be 
these natural polyphenols are mediating their effect on cancer cells at transcriptome level by 
inducing apoptosis related genes. Moreover the down regulation of Jmjd3 and down 
regulation of Bcl-2with treatment of sulphoraphane and curcumin may be correlated to have 
a conjoint effect on apoptosis induction in breast cancer cells. Further studies at protein level 
may unravel hidden dimensions of Jmjd3 in the induction of apoptosis in breast cancer cells 
which may create a better therapeutic avenue for treating cancer patients in future. 
Key words: apoptosis, cancer, MDA-MB-231, sulforaphane, Curcumin, Bcl-2, Bax, Jmjd3 
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INTRODUCTION
Breast cancer in women has been a glooming issue in the medical history for decades. The 
prevalence of breast cancer patients reflects that it is the most common cancer in women in 
developing and developed countries.  The morbidity and mortality rate of breast cancer patients 
indicates that one in ten of all new cancer cases diagnosed worldwide every year is a cancer in 
female breast. The modern unhealthy lifestyle makes women susceptible to reproductive and 
hormonal risks at their early ages. The occurrence of breast cancer is also dependent on such 
factors. The initiation and progression of breast cancer has been perceived to be caused by the 
accumulation of genetic mutations which lead to aberrant cellular functions. DNA is the genetic 
material which controls all the principal cellular functions. Aberrant genomic alterations result in 
deregulation of gene expression and disruption of signaling networks that control cell 
survivability and proliferation. Uncontrolled cell proliferation leads to cancer that arises in 
individuals through genetic mutations, either inherited or sporadic. This may result in the 
activation of oncogenes and the inactivation of tumor suppressor genes. There are some specific 
genes that control the cells to grow, divide in to new ones and then die after a particular time. 
Oncogenes are the genes that enhance the cell division where as tumor suppressor genes slow 
down cell division forcing them to die timely. Mutations in DNA that ‘turn on’ the oncogenes or 
‘turn off’ the tumor suppressor genes are likely to be the impelling cause of transformation of a 
normal breast cell to a cancerous one. For example, certain inherited mutations like mutation in 
the BRCA genes (BRCA1 and BRCA2) can cause breast cancer in females. The more recent 
discoveries claim that along with the genetic alterations, some reversible alterations in the 
genome play important role in cancer initiation and progression. These modifications occur at the 
histone tails and in the DNA which is known as the epigenetic modifications. Epigenetic 
modifications are the heritable changes in the gene expression without the change in DNA 
sequence. These epigenetic mechanisms are very crucial in developmental processes as well as in 
maintenance of specific gene expression patterns. Any abnormality in these regulatory 
mechanisms can lead to altered gene function and malignant cellular transformation. Aberrant 
changes in the epigenome are a hallmark of cancer. The component of the epigenetic 
machinery in cancer includes methylation in the promoters of DNA ,modifications in the histone 
proteins including acetylation at lysine residues, methylation at lysine and arginine residues, 
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phosphorylation at serine and threonine residues, ubiquitination and sumoylation at lysine 
residues. These modifications play essential roles in regulating chromatin structure and gene 
expression, mainly by altering stability and accessibility of nucleosome 
(Kouzarides,2007).Posttranslational modifications in the amino and carboxyl-terminal of histone 
tails as well as  in the globular domains of histone protein are driven by authoritative association 
of several modulatory enzymes like Histone Methyl Transferase(HMT)/Histone 
Demethylase(KDM), Histone Acetyl Transferse(HAT)/Histone Deacetylase(HDAC) etc. 
Methylation at lysine residues can occur several times (mono, di or tri-methylation) and each 
modification results in to different functions. In general acetylation at lysine residue results in to 
transcription activation and methylation at lysine residue is associated with transcription 
activation or repression depending on the residue and degree of methylation. H3K9 or H3K27 
methylation or H4K20 methylation, results in to gene silencing. In contrast, H3K4, H3K36 and 
H3K79 methylation is correlative with transcriptional activation. According to the Histone code 
hypothesis covalent modifications of histones have regulatory hold on gene expressions that have 
several functional consequences. Recent investigations shows that histone modifications have 
crucial roles in gene(oncogene/tumor suppressor gene) transcription and expression, DNA repair, 
cell proliferation, mitosis, meiosis ,cell survivability and apoptosis. Apoptosis or programmed 
cell death (PCD) is an important hall mark of cancer progression (Hanahan et al., 2000).It is a 
fundamental process to development and maintenance of cellular homeostasis. 
  
APOPTOSIS IN CANCER: 
Cells have the ability to grow, divide and differentiate according to the signals they get. Normal  
cells respond to both growth promoting and growth inhibitory signals that decide whether the 
cells should divide, differentiate or die. Cancer cells divide in an uncontrolled manner escaping 
from programmed cell death.Deregulation of certain gene expression or signalling mechanism 
appears to be the cause of initiation and execution stages of apoptosis that results in the 
insufficient elimination of tumor cells conferring acquired resistance to chemotherapeutics or 
enhancing the uncontrolled migration of cells leading to metastasis.Therefore it is essential to 
identify and target those disabled pathways which may effectively inactivate tumor progression 
and drive the cells towards the programmed cell death .To date apoptosis is thought to be 
regulated by two classical pahways;i.e. extrinsic and intrinsic pathways(Elmore,2007).Extrinsic 
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pathway is associated with transmembrane ligand induced activation of death receptors and 
activation of procaspase-8 which ultimately activate caspase-3, driving the cells towards 
programmed cell deth.The intrinsic pathway is triggered by the response of internal apoptotic 
stimuli that results in to the change in the mitochondrial transmembrane potential. Activated by 
this response several pro apoptotic proteins like cytochrome-c,Smac/DIABLO,serine protease 
HtrA2/omi are released which activate procaspase 9 and Apaf1 to form apoptosome or death 
complex. This in turn activates the procaspase 3 and induces apoptosis. Apoptosis is well 
characterized by typical morphological and biochemical hall marks including chromatin 
condensation, cell shrinkage, nuclear DNA fragmentation, membrane blabbing 
etc(Hengartner,2000).The intrinsic and extrinsic paths of apoptosis are described below in fig-1. 
 
 
Fig1: Extrinsic and Intrinsic mechanisms of apoptosis 
 
EPIGENETIC REGULATION OF APOPTOSIS: 
Apoptosis is a cellular event that removes unwanted cells from the body during normal growth 
and development in multi cellular organisms and also is the consequence of reactivity of cells 
towards various DNA damaging agents or chemotherapy. A common feature to all the cells 
undergoing apoptosis is the chromatin condensation and fragmentation of nuclear DNA. These 
nuclear changes during apoptosis are associated with epigenetic modifications and apparently 
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regulated under the action of post translational histone modifications. Chromatin structures of 
transcriptionally active regions are characterized with greater accessibility than to the 
transcriptionally inactive heterochromatin structure. Histone modifications like phosphorylation, 
acetylation, deacetylation, methylation and demethylation have long been suggested to affect 
chromatin structure and accessibility. Epigenetic modifications are likely to have a commanding 
role over the nuclear changes experienced by apoptotic cells. Hence unraveling the hidden 
dimensions of the association of these epigenetic modulatory enzymes and their role in 
controlling the programmed cell death would certainly provide a comprehensive knowledge in 
context of breast cancer progression. Moreover activation or inhibition of these principle 
regulators in the presence of epigenetic modulatory drugs may entail the regulatory mechanisms 
of programmed cell death in cancer cells.  
 
EPIGENETIC DRUGS: 
Unlike the genetic mutations in cancer, epigenetic alterations can be reprogrammed by targeting 
the enzymes involved in the chromatin packaging and transcription of key regulatory genes. 
Hence drugs that restore the epigenetic balance by targeting such regulatory enzymes, show 
amazing therapeutic potential by reverting back the aberrant gene expression associated with 
different types of cancers. Researchers are finding ways to regress epigenetic changes by 
specifically targeting abnormal cells while minimizing damage to normal cells. In contrast with 
standard chemotherapeutics for cancer treatment that affect both abnormal and normal cells at 
higher dosages, epigenetic drugs more specifically target the chemical modifiers that bring 
heritable change in the gene expression even at lower dosages. Several epigenetic therapies 
including drugs targeting DNA methylation, Histone acetylation and deacetylation pathways 
have already been approved by the Food and Drug Association (FDA) and many more are in the 
preclinical trial phases for cancer treatment and prognosis. Environmental factors and diet 
directly influence epigenetic mechanisms in humans. Dietary polyphenols from green 
tea(epigallocatechin gallate-EGCG), soybeans(Genistein), turmeric(curcumin), 
broccoli(sulforaphane), grapes(resveratrol) and others have shown to possess several cell-
regulatory activities within cancer cells(Link et al.,2010).Bioactive plant polyphenols mediating 
epigenetic modifications are often involved with reactivation of tumor suppressor genes, 
repression of oncogenes and induction of apoptosis in many types of cancer. They often alter the 
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DNA methylation pattern and histone modifications required for gene activation or silencing 
during cancer chemo prevention .In this study we target the natural polyphenols curcumin and 
sulforaphane which shows potential DNMT inhibitory, HAT inhibitory and also HDAC 
inhibitory activity. Moreover the role of these natural polyphenols in the induction of apoptosis 
in breast cancer cell will certainly create an avenue for effectively treating breast cancer patients. 
 
SULFORAPHANE: 
Sulforaphane (SFN) is an isothiocyanate organosulphuric compound that is derived from 
broccoli extracts and other crucifer vegetables like brussel sprouts, cabbage, cauliflower 
etc(Zhang et al.,1992).It exhibits anticancer and antimicrobial properties in in-vitro and in-vivo 
applications. It is produced when the enzyme myrosinase transforms glucoraphanin, a 
glucosinolate, into sulforaphane .Glucoraphanin (GR) or 4-methylsulfinylbutyl glucosinolate is 
the major glucosinolate found in broccoli. The enzyme myrosinase gets activated, released upon 
physical damage to the plant and catalyzes the hydrolysis of GR to sulforaphane (SFN) (van 
Poppel et al,1999).The structure of sulforaphane is shown below in fig-2.  
 
Fig-2:Metabolism and structure of Sulforaphane(Boddupalli et al,2012) 
 
CURCUMIN: 
Curcumin (1, 7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione)),a hydrophobic 
polyphenol is derived from the dietary spice turmeric: the dried ground rhizome of the perennial 
herb Curcuma longa Linn. It is commonly called diferuloylmethane and exhibits keto-enol 
tautomerism. Commercial curcumin is a mixture of curcuminoids, containing approximately 
77% diferuloylmethane, 18% demethoxycurcumin, and 5%bisdemethoxycurcumin (Anand et al., 
2007). Curcumin is least soluble in water but quite soluble in organic solvents. The two 
tautomeric forms of curcumin are described below in fig-3. 
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                   Keto form                                                                    Enol form 
 
Fig-3: Tautomeric forms of curcumin (http://chemcool.tumblr.com/post/23659551189) 
Curcumin has been well characterized for its anti-inflammatory, antioxidant, anti-cancerous, 
chemo preventive and potentially chemotherapeutic properties. Curcumin is found to modulate 
the activity of epigenetic modulatory enzymes like histone acetyltransferases, histone 
deacetylases, DNA methyltransferase I, and miRNAs(Reuter et al.,2011)  controlling the ‘on’ 
and ‘off ’ switches of  tumor inducing genes. It has a putative chemotherapeutic effect on killing 
cancer cells by inducing programmed cell death.  
The epigenetic changes leading to the development of human cancer are accompanied by 
alterations in the chromatin architecture and function. These modification statuses of chromatin 
are instrumental in regulating gene expression and genome stability. Histone methylation and 
demethylation can influence chromatin condensation and poise genes for either transcriptional 
repression or activation, depending on how the modification is interpreted and translated in a 
specific circumstance. Histone methyltransferases and demethylase enzymes are essential for 
development and maintenance of cellular homeostasis whereas deregulated expression has been 
linked to human disorders such as cancer(Albert et al.,2009).H3 lysine (K) 27  methylation 
(mono-, di-, and tri-methylation) induces transcriptional silencing, and thereby controls gene 
expression patterns. Tri-methylation mark at H3k27 is reckoned as repressive histone 
modification mediated by the histone methyltransferase EZH2 (Enhancer of Zest Homologue 2), 
which is a component of the Polycomb group (PcG) complex 2 (PRC2). Aberrant histone 
methylation at lysine 27 of histone 3 protein (H3K27me3) derived by the abnormal EZH2 
expression has been associated with various cancers including breast cancer (Yoo et al.,2011). In 
contrast to this phenomenon, the lysine-specific demethylases (LSDs) and the Jumonji C (JmjC) 
domain containing histone lysine demethylases (KDMs), UTX and JMJD3 are responsible for 
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reverting the repressive state to an activated state by erasing the repressive methyl marks from 
the histone tail. Maintenance of histone methylation, required for growth, differentiation, gene 
expression and cellular proliferation counts a balance between methylases and demethylases. 
According to the recent findings, aberrant expression of methylases and demethylases are 
involved in course of tumor initiation and progression. DNA methylation/demethylation 
pathways, Histone methylation/demethylation pathways are aberrantly deregulated in cancer 
cells (Patra et al., 2002). The Jumonji C (JmjC) domain containing lysine demethylase, JMJD3 
belongs to the second and largest class of histone demethylase (KDMs) more specifically to 
KDM6 cluster in mammalian cells. These are Fe(II) and 2-oxoglutarate-dependent demethylase 
enzymes specific for H3K27me3/me2(Shi et al.,2007).Aberrant expressions of these writer or 
eraser enzymes have been implicated in the course of tumor initiation and progression. Mis-
erased or mis-written histone methyl marks are associated with many types of cancer. Hence 
mechanistic insight into the role of histone demethylase, JMJD3 enzyme in progression of cancer 
and its influence in presence of natural polyphenols Sulforaphane and Curcumin, on 
programmed cell death will pave the way for the development of new therapeutic intervention 
for the treatment of cancer.  
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REVIEW OF LITERATURE 
 
Apoptosis, or programmed cell death occurs by two regulatory pathways. One may be through 
the activation of mitochondria caspase cascades or though the death-receptor caspase cascades. 
The important hallmarks of apoptosis are changes in Bcl-2 protein family ratios (both increased 
pro-apoptotic proteins and decreased anti-apoptotic proteins), poly (ADP-ribose) polymerase 
(PARP) cleavage and decrease in IAP, release of cytochrome C from the mitochondrial 
membrane, nucleosome DNA fragments, chromatin condensation, and activation of caspases. 
Apoptotic pathways are generally deregulated in almost all the cancers. Cells proliferate 
uncontrollably escaping from programmed cell death worsening the stage of cancer progression. 
Bcl-xl, Bcl-2, mcl-1, and Bax are the functional members of the Bcl-2 gene family. They 
function as repressors or promoters of apoptosis. The Bcl-2 oncogenes behave as a broad anti 
apoptotic factor and promote tumor cell survival inhibiting several cell death mechanisms 
induced by chemotherapy or radiation therapy. Over expression of anti apoptotic Bcl-2 is 
common in many types of human cancer and is very often correlated with decreased 
susceptibility to chemotherapeutics and inhibition of cell death induced by many stimuli, 
including hypoxia, nutrient deprivation, growth factor deprivation, and oxidative stress (Yip et 
al.,2008).  In contrast, with the oncogenes Bcl-2, the Bax gene is a promoter of apoptosis and 
helps in prognosis of cancer in humans (Friess et al.,1998).Anti-apoptotic molecule such as Bcl-
2 or Bcl-xl can inhibit the activation of Bax following a repression of death signal(Gross et 
al.,1999).In patients with prostatic cancers, there is a high ratio of Bcl-2(apoptotic suppressor) to 
Bax(apoptotic activator) which increase their resistance towards radiotherapy. Hence the Bcl-
2/Bax ratio serves as a potential molecular marker for predicting radio resistance of prostatic 
tumors (Mackeya et al., 1998).Bax acts s a tumor suppressor and activates tumorigenesis in a p53 
dependent mechanism and stimulates apoptosis in vivo (Yin et al.,1997). 
Cancer progression is concordant with aberrant activation or silencing of many targeted 
genes that allow cells to survive and multiply in an uncontrolled manner. Interestingly, SFN can 
modulate these targets and redirect their activities towards apoptosis or cell cycle arrest, thereby 
eliminating unwanted cells from the general population. At initial stages of cancer, SFN 
potentially blocks carcinogenesis by inhibiting phase I enzymes that are bioactivators of 
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chemical carcinogens and induce phase II enzymes which protect our cells or tissues from 
damages due to chemical carcinogens and enhance the transcription of tumor suppressor genes 
(Fimognari et al., 2007). The multi targeted ‘‘blocking” of SFN includes decrease in 
CYP1A1,CYP2B1/2,CYP3A4 phase I enzymes and increase in CYP4A10,CYP4A14 
,CYP39A1enzymes, increase in NQO-1,GST,c-GCS,UGT phase II enzymes, increase in level of  
anti-oxidants Glutathione peroxidase 3,Thioredoxin reductase 1 and 3,Proteasome subunits 26S 
,alpha 1 and 3, beta 5, and  ,increase in CDK 4, 7 and 9 ,cell cycle and cell growth Cyclins D1, 
E2 and T2, ,increase in transcription factors CREB binding protein etc(Clarke et al.,2008). SFN 
induces apoptosis in cancer cells by increasing caspase3 activity, increase in BAX:Bcl2 ratio, 
cytosolic activation of smac/Diablo, increase in p53 status ,increasing PARP activity, decreasing 
IAP level(Karmakar et al.,2006).SFN has been identified as a HDAC(Histone Deacetylase 
Inhibitor) inhibitor in human embryonic kidney 293 (HEK293) cell(Myzak et al,2004) . SFN is 
found to potentially inhibit the growth of prostate cancer xenografts by altering histone 
acetylation and HDAC activities in vivo. In human subjects, an intake of 68 g broccoli sprouts 
was found to inhibit HDAC activity in circulating peripheral blood mononuclear cells, with 
incidental induction of histone H3 and H4 acetylation (Roderick et al., 2007). SFN inhibits the 
progression of benign tumors to malignant transformation (Conaway et al.,, 2005), angiogenesis 
(Bertel et al., 2006)and metastasis(Thejass et al.,2006).HepG2 and HeLa cells showed apoptotic 
body formation and the accumulation of the cells in sub-G1 phase in presence of sulforaphane 
(Park et al., 2007).Induction of Fas ligand and activation of caspase-8,caspase-3,and poly(ADP 
ribose) polymerase are shown to be modulated by SFN. Also decreased Bcl-2 expression, release 
of mitochondrial cytochrome c, activation of caspase 9 and 3 into the cytosol are 
characteristically found  in breast cancer cell lines treated with SFN(Pledgie-Tracy et al.,2007). 
In addition, it has been shown that down regulation of IAP family proteins including cIAP1, 
cIAP2, and XIAP, SFN-induced cell death also includes Bax activation and apaf-1(apoptotic 
protease activating factor-1) induction (Choi et al., 2007).In PC3 and DU145 human prostate 
cancer cell lines, SFN-induced apoptosis is demonstrated by formation of reactive oxygen 
species (ROS) and change in membrane potential of mitochondria leading to cytosolic release of 
cytochrome c (Singh et al., 2005). The various cellular responses in presence of sulforaphane 
(SFN) are described in fig-4 below. In skin cancer cells, sulforaphane is seen to suppress cancer 
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progression by reducing PcG(Poly comb Group) protein level through activation of a 
proteasome-dependent mechanism (Balasubramanian et al.,2011). 
 
 
Fig-4: Role of SFN in various cellular processes involved in cancer progression 
 
Due to the anti carcinogenic properties, SFN is a potential therapeutic agent that can act against 
any type of cancer at its early, intermediate or late phases and can reduce the process of 
carcinogenesis. It has already been proven its potential in phase II clinical trials and it will create 
a new avenue for clinical applicability to cancer patients in near future. 
Curcumin has a wide array of molecular targets associated with numerous biochemical 
and molecular cascades regulated epigenetic modulation of gene expression. Curcumin 
specifically inhibits p300/CREB-binding protein (CBP) (Marcu et al., 2006). Curcumin inhibits 
the p300-mediated acetylation of p53 in vivo and significantly decrease acetylation of HIV-Tat 
protein in vitro as well as checks proliferation of the virus(Balasubramanyam et 
al.,2004).Curcumin activates caspase-3–mediated apoptosis and PARP cleavage in brain glioma 
cells as a mechanistic histone hypoacetylation (Kang et al. 2006). Curcumin is found to have 
potent DNA hypomethylation capacity, thrusting regulatory hold in various patho-physiological 
conditions like inflammation and cancer (Liu et al.,2009).In-silico studies showing molecular 
docking of the interaction between curcumin and DNMT1 suggests that the catalytic thiolate of 
DNMT1is covalently blocked by curcumin resulting in to inhibition of DNA methylation. 
Curcumin’s effect on HDAC expression is prominently investigated in past years. One study has 
revealed that expression of HDAC 1, 3, and 8 were significantly reduced in curcumin treated 
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Raji cells compared to the untreated Raji cells. Also there was an increase in the levels of 
acetylated histone H4 (Liu et al. 2005). Similarly HDAC1 and HDAC3 were significantly 
decreased after treatment with curcumin (Chen et al. 2007). By contrast with treatment of 
curcumin, HDAC2 expression was restored as a critical component of corticosteroid anti-
inflammatory molecule in impaired lungs of patients with chronic obstructive pulmonary disease 
(Meja et al. 2008). In acute myelogenous leukemia cell line HL-60, curcumin is seen to induce 
apoptosis through cleavage of Bid, activation of casapase 8, release of cytochrome c and its 
suppression is related with ectopic expression of Bcl-2 and Bcl-xl(Anto et al.,2002). Curcumin 
induces apoptosis in human breast cancer cell MCF7 through induction of Bax in a p53-
dependent  manner(Choudhuri et al.,2002).The various epigenetic modifications caused by the 
action of curcumin and its role in the induction of apoptosis are described below in fig-5. 
 
Fig-5: Effect of Curcumin on epigenetic modifications and apoptotic pathway activation 
 
H3K27 demethylases are proposed to act as tumor suppressor genes with opposite to the 
action of  oncogenic PcG proteins(Rotili et al.,2011).The Jmjd3gene is located on chromosome 
17 near the p53 tumor suppressor gene. When there is an allelic loss at 17p13.1, including both 
p53 and JMJD3, more aggressive tumor are characteristically formed (Agger et al., 1989). 
Epigenetic silencing of the INK4A-ARF tumor suppressor locus encoding tumor suppressor 
genes p16INK4A and p14ARF is associated with the development of human cancers. JMJD3 
imparts the reactivation of INK4A-ARF by eliminating repressive H3K27me3 marks during 
induction of stress induced senescence or oncogenesis (Agger et al., 1989). It has been suggested 
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that in breast cancer cell lines MCF7 (i.e. an estrogen positive cell line), the activation 
of BCL2 transcription factor is dependent on the simultaneous inactivation of the H3K27 
methyltransferase, EZH2 at a poised enhancer by the ERα-dependent recruitment of histone 
demethylase JMJD3.Depletion of JMJD3 has resulted in the induction of apoptosis followed by 
decrease in Bcl2 expression and decrease in DNA content (Svotelis et al., 2011). But in estrogen 
negative cancer cell lines, the regulatory mechanisms are yet not been well evidenced. Therefore 
in this study we have experimented whether the Bcl2 depletion and Bax induction by the natural 
polyphenols sulforaphane and curcumin is dependent on transcriptional expression of Jmjd3. 
Hence we can presume that JMJD3 could provide an important barrier to tumorigenesis and 
induce apoptosis through regulated expression of pro apoptotic and anti apoptotic genes. 
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OBJECTIVES 
 
1. To analyze the effect of natural polyphenolic compounds 
Sulforaphane and Curcumin as epigenetic modulators on breast 
cancer cell line MDA-MB-231. 
 
2. To observe cellular and morphological changes in MDA-MB-231 
cells as a sign of apoptosis induction 
 
3. To analyze the transcriptional level of Jmjd3 a key Histone 
demethylase in response to the treatment with Sulphoraphane and 
Curcumin. 
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MATERIALS AND METHODS 
1.  Maintenance of cell line 
Human breast carcinoma cell line MDA-MB-231 was obtained from the National Centre for cell 
Science(NCCS), Pune, India. The cells are known to be of epithelial breast adenocarcinoma in 
origin .This cell line was maintained in Dulbecco’s modified eagle’s medium(DMEM) with 10% 
fetal bovine serum,2mM L-glutamine and 100 units/ml penicillin-streptomycin sulphate 
(invitrogen).This cells were seeded properly in flask with the growth  media and left for 2-3 days 
to get confluency. Then these cells were trypsinized and counted to be reseeded in 6 well plates 
or 96 well plates with the presence of media. When the cells get confluent after 24 hours, drugs 
of a particular IC50 value were administered to the cells. The drug treatment was done with 
sulforaphane (SFN) and curcumin (all purchased from sigma), for a period of 0, 24, 48,72hrs. 
2. MTT Assay: 
To determine the cell proliferation capacity in presence of drugs, MDA-MB-231 cells were 
seeded in 96 well plates at a density (3000 cells per well) based on the doubling time in presence 
of  200µl growth media (10% FBS) and incubated for 24 hours in incubator containing 5% CO2  
at 37°C .Uniform cell seeding was done to obtain a perfect dose response effect of  drugs. The 
drugs of interest were curcumin and sulforaphane, diluted at different concentrations in growth 
media. After 24 hours of  seeding, the existing media was removed and replaced by fresh media 
along with various concentrations of drug. Then the plates were incubated for 24,48and 72 hours 
in the CO2 incubator. To detect the cell viability, MTT working solution was prepared from a 
stock solution of 5mg/ml in growth medium without FBS to the final concentration of 
0.8mg/ml.100 µl of MTT solution was added and incubated for 3-4 hours. Addition of MTT is 
done in the dark as this solution is light sensitive. After 4 hours of incubation the MTT solution 
was discarded from each well and 100 µl of DMSO solvent was added in each well under dark 
followed by an incubation of 20-30 minutes. The metabolically active cells reduce the yellow 
tetrazolium solution of MTT in to formazan complex which on addition of solvent turns in to 
purple color solution. Then the colorimetric estimation of formazan product is done at 565nm 
with a reference 595nm wavelength in a microplate reader. The data was plotted against drug 
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concentration and the percentage of viable cells was known. From the plotted graph the IC50 
value was obtained which signifies the drug concentration at which 50% of the cells are viable.  
3. Isolation of total cellular RNA: 
The total cellular RNA was isolated from MDA-MB-231 cell lines by Trizol (Sigma-
Aldrich,USA) method according to manufacturer’s instructions. In brief, (1x106) cells were 
washed with 1 ml of 1xPBS (pH 7.4) and spun down at 1300 g for 5 min. Then the pellet was re-
suspended in 1 ml of Trizol reagent to lyse the cells. In this lysed cellular mix, 200μl chloroform 
was added (for phase separation and disintegration of lipid bilayer), shaken vigorously for 15 sec 
and incubated at room temperature for 15 minutes. Contents were centrifuged at 12000g for 15 
minutes at 4 °C to separate components in organic, interphase and in aqueous phase. Aqueous 
phase was transferred to a fresh eppendrof tube and RNA was precipitated using 500μl of 
isopropyl alcohol. RNA pellet was collected by centrifugation at 12000g for 10 min at 4 °C, 
washed with 70% ethanol then again centrifuged at 7500g for 5 minutes. Then it was dissolved 
in 20μl of autoclaved DEPC treated water. 
4. Quantification of total cellular RNA: 
The concentration of isolated total cellular RNA was measured using a nanodrop UV 
spectrophotometer analyzer. It was likely that a standard preparation of RNA should have a 
260/280 ratio of 1.8-2 and 260/230 ratio 2-2.2 which indicates the preparation of RNA free of 
protein and oligopeptide contamination.  
5. Complementary DNA (cDNA) preparation: 
First strand cDNA was synthesized using Thermo Scientific Revert Aid First Strand cDNA 
Synthesis Kit. In PCR tube, 1µl of oligo (dT) 18 primer, 1 µg of total RNA(drug treated) was 
taken and the volume was made up to 12 µl with the addition of nuclease free water. The mixture 
was gently mixed with pipetting and was briefly centrifuged. Then the mixture was incubated at 
65°C for 5 minutes. After 5 minutes, the tubes containing mixture was snap cooled on ice. Then 
to this 12 µl mixture, 4 µl of 5X Reaction Buffer, 1 µl of RiboLock RNase Inhibitor (20 u/ µl), 
2 µl of 10 mM dNTP mixture and1 µl of Revert Aid M-MuLV Reverse Transcriptase (200 u/ µl) 
was added. The total volume of the mixture now became 20 µl. All the steps were performed 
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while kept on ice. The total mixtures were mixed thoroughly with gentle pipetting and spin down 
for few seconds to ensure proper mixing. Then the mixture was set for reverse transcriptase-PCR 
with incubation at 42°C for 60 minutes followed by end incubation at 70°C for 5 minutes. The 
cDNA synthesized from the RNA was stored in ice at -20°C for further use. 
 
6. Real Time-PCR: 
Real time Polymerase Chain Reaction or qRT PCR is a method that allows exponential 
amplification of DNA sequences and simultaneously quantitates differences in mRNA 
expression. This system includes a DNA binding cyanine dye such as SYBR green that 
specifically binds to the major groove of double strand DNA but not to the single stranded 
DNA.SYBR green binds to the amplicons accumulated during PCR process which is 
proportional to the fluorescence emission of the dye .One reference dye(ROX dye) was used to 
serve as an internal reference for normalization of the SYBR green fluorescent signals.ROX dye 
allows for correction of well-to-well variation due to pipetting inaccuracies and fluorescence 
fluctuations. Four genes were taken for the experiment, three of which were test genes and one 
was housekeeping gene as a reference. Housekeeping gene are generally taken as reference genes 
to check for the expression of test genes i.e. how much fold the test gene’s expression has 
increased or decreased with respect to normal gene expression. For this experiment the test genes 
were Bcl-2, Bax and Jmjd3 and reference gene used was β-actin.  
The total reaction volume prepared was 5 μl . 
Calculation: 
4 genes were taken, therefore, 
4 genes x 3 replicates×2 treatment = 24 reactions~26 reactions (to avoid inaccuracy  
     due to pipetting error)(12 reactions for each treatment) 
26 reactions x 5 μl = 130μl total volume was to be prepared. 
 
SYBR ® Green master mix dilution: 
The stock SYBR ® Green master mix solution was of 2X concentration(containing optimized 
mixture of SYBR green dye+MgCl2 +dNTPs+ Taq DNA Polymerase+ qPCR Reaction buffer)  
and from this working solution of 1 X concentration was taken.  
 2X x (? µl) = 1X x 130µl  
18  
 
=> (? µl) = 1X x 130µl / 2X  
 = 65µl  
SYBR ® Green master mix= 65µl 
Reference dye: 
For 100 µl of mixture reference dye taken, is 1 µl 
Hence for 130 µl reaction mixture reference dye taken was,130 µl/100=1.3 µl 
cDNA was diluted at 1:20 ratio with addition of nuclease free water. 
For each reaction we required 1μl of diluted cDNA(SFN treated and curcumin treated). 
Therefore, for 26 reaction= 1x26=26μl (for each treatment 13 μl template was needed). 
Primer:  
The stock solution of primer contained 10μM, from which we required 500nM for each reaction 
10 μM x (? μl) = 500x10 -3μM x100 
=> (? μl) = 500x10 -3μM x100 / 10 μM 
= 5μl(each for forward and reverse primer) 
Reference dye=1.3 µl 
Forward Primer=5 µl 
Reverse primer= 5 µ 
Template=26 µl  
Autoclaved distilled water=27.7µl 
Total=65 µl 
Then a semi master mix was prepared with the addition of SYBR® Green master mix + 
Reference dye +water= (65 +1.3+27.7) μl= 94μl (for 4 genes) 
 
                                            23.5μl   23.5μl    23.5μl     23.5μl 
             Forward Primer= +1.25 
             Reverse Primer= +1.25 
                              Total= 26(for 2 treatment) 
 
                                   13μl          13μl  (for 5 μl of reaction 1 μl template is needed,  
                                                    for 13μl of reaction template needed= 13/5=2.6) 
          Template=    + 2.6          + 2.6 
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                Total= 15.6 μl (for each triplicate) 
 
    5.20 μl   5.20 μl   5.20 μl 
For Real time PCR analysis mainly 2 types of primers are used: Forward primer and reverse 
primer. The primers were specifically designed with the help of NCBI primer blast tool. The 
primer sequence, their melting temperature and product length is shown below in table-1  
Table-1: Table showing the sequence of the forward and backward primers: 
Name of the 
primer 
           Type        Sequence Product 
length 
 
Bcl-2 
 
        
Forward 
5’CCTGTGGATGACTGAGTACC 3’  
128bp 
        
Reverse 
3’GAGACAGCCAGGAGAAATCA 5’ 
 
Bax 
 
        
Forward 
5’TTCATCCAGGATCGAGCAG 3’  
94bp 
        
Reverse 
3’ CGCTCAGCTTCTTGGTGG 5’ 
 
Jmjd3 
 
 
        
Forward 
5’GGAGACCTTTATCGCCTCTG 3’  
116bp 
        
Reverse 
3’ TCCCTTTCACCTTGGCATT 5’                         
 
β actin 
 
        
Forward 
                         
5’CTGGAACGGTGAAGGTGACA 3’                             
 
140bp 
        
Reverse 
 
3’AAGGGACTTCCTGTAACAACGCA5’                            
 
Real-time PCR was carried out in Eppendorf Masterplex Real Time PCR. The experiment was 
set up with the following PCR program. The threshold frequency taken was 33%. The cycle 
temperatures taken were as follows described in table-2: 
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Table-2: Cycle temperature and time for qRT-PCR: 
Stage Temperature° C Time          Cycle 
 
Stage 1 
 
 
95 
 
20sec 
 
            1 
Stage 2 95 
55 
68 
15sec 
15sec 
20sec 
           40 
Stage 3 95 
60 
95 
15sec 
15sec 
15sec 
            1 
 
The melting curve was analyzed by the inbuilt software and the change in relative gene 
expression with respect to β actin was detcted as fold change at logarithmic scale. 
 
7. Clonogenic Assay for measuring Cell survivability: 
In brief, media form stock culture of cells actively growing in monolayer was removed, then 
washed with 1x PBS for 2 times for removal of dead cells. Then 500µl of trypsin was added and 
incubated for 5-10 minutes to detach the cells. Trypsin was neutralized with the addition of 
500µl media. Then the cells were collected in a suspension. The number of cells per milliliter in 
this suspension is then counted using a hemocytometer . From this stock culture, approximately 
600 cells were seeded into each well of a 6 well plate. The plate was incubated for approximately 
2 weeks. Each single cell divides many times and forms a colony that is easily visible with the 
naked eye, especially if it is fixed and stained. Hence after 2 weeks 1ml of 1x ice cold PBS was 
added and left for 10minutes followed by incubation in absolute ice cold methanol for 10-15 
minutes. Then it was stained in 0.05%crystal violet and kept for 10-15 minutes undisturbed. To 
avoid excess staining it was de stained  in normal water for four times. The plates were seen 
under UV filter using Epi-fluorescent Microscope (Nikon TE 2000E). All the cells that make up 
the colony are the progeny of a single cell. For the 600 cells seeded into the dish, the number of 
colonies counted should be at least 50 or above. 
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8. Soft agar colony forming assay: 
Anchorage-independent growth is one of the hallmarks of malignant transformation of cells .The 
Soft Agar Assay for Colony Formation is an anchorage independent growth assay, which is 
considered the most stringent assay for measuring proliferation of cells in a semisolid culture 
media and its sensitivity towards carcinogenic inhibitors. The soft agar plate provides a 3D 
system which mimics our cellular environment. Standard soft agar assays are usually performed 
in 35mm dishes, cells pretreated with carcinogenic inhibitors or drugs are cultured with 
appropriate controls in soft agar medium for 14-21 days. Following this incubation period, 
formed colonies can either be analyzed morphologically using cell stain and quantifying the 
number of colonies formed per well. 
8.a. Preparation of Base Agar: 
0.7% agar was melted in a microwave. Equal volumes of 2X DMEM with 10% FBS and 0.7% 
agar were mixed thoroughly. Then 1.5ml of this mixture was added to each 35mm petri plates 
and set aside for 5 minutes to solidify. 
8.b. Preparation of Top Agarose : 
Cells pretreated with drugs were trypsinized and  the number of cells per ml was counted.5000 
cells were taken for each plate.0.8% agarose was melted in microwave.3ml of 2X DMEM+10% 
FBS and 3ml of 0.8% agarose was added to the cell suspension in a 10ml tube. The mixture was 
gently swirled for appropriate mixing.1.5ml of this mixture was added to each of the agar dishes 
made previously. To be in the safer side 3-4 replicates were prepared. Negative control without 
cells and positive controls without treatment were taken. The plates were incubated at 37°C in 
humidified incubator for 14-21 days. The cells were fed 1-2 times per week with DMEM. All the 
steps were done aseptically to avoid any microbial contamination.  
8.c. Staining: 
After 21 days, the plates were stained with 0.5mi of 0.005% crystal violet for 30-60 minutes. The 
excessive stains were removed by washing with normal water for 2-3 times. The colonies were 
counted using a dissecting microscope. 
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9. Comet Assay to measure DNA damage: 
Comet assay is a gel electrophoresis with fluorescence microscopy based method used to 
visualize migration of DNA strands and to measure DNA damage from individual eukaryotic 
cells. Circular comet head contains undamaged DNA having high molecular weight and the 
comet tail represents damaged DNA. Longer and brighter tail shows higher level of DNA 
damage.  
9.a. Agarose preparation 
Two water baths were equilibrated at 40 °C and 100 °C respectively. Than 1% low gelling-
temperature agarose was prepared by mixing powdered agarose with distilled water in a glass 
beaker or bottle. The bottle was placed in the 100 °C water bath for several minutes and was 
transferred into a 40 °C water bath.  
9.b. Slide Percolating 
Agarose-precoated slides were prepared by dipping the slides into molten 1%   agarose and 
wiping one side clean. It is best to work in a low-humidity environment to ensure agarose 
adhesion. Agarose was allowed to air-dry to a thin film. Slides can be prepared ahead of time and 
stored with desiccant.  
9.c. Sample Preparation 
A single-cell suspension was prepared using enzyme disaggregation or mechanical dissociation. 
The cells were kept in ice-cold medium or phosphate-buffered saline to minimize cell 
aggregation and inhibit DNA repair. Using a hemocytometer or particle counter, cell density was 
adjusted to about 2 × 10
4 
cells/ml in phosphate-buffered saline lacking divalent cations. Slides 
were labeled on frosted end using a pencil. 0.4 ml of cells into a 5 ml plastic disposable tube was 
pipette out. 1.2 ml 1% low-gelling-temperature agarose at was added at 40 °C. 1.2 ml of cell 
suspension onto the agarose-covered surface of a pre-coated slide was mixed by vigorous 
pipetting. Agarose was allowed to be gel for about 2 min. 
9.d. Lysis and Electrophoresis 
After agarose has gelled, slides were submerged in a covered dish containing A1 lysis solution 
[1.2M NaCl, 100mM Na2EDTA, 0.1% sodium lauryl sarcosinate, 0.26M NaOH (pH.13)]. 
Samples were lysed overnight (18−20 h) at 4 °C in the dark. After overnight lysis, slides were 
removed carefully and submerge in A2 rinse solution [0.03M NaOH, 2mM na2EDTA (pH 12.3)] 
for 20 min at room temperature (18−25 °C). The process was repeated two times to ensure 
23  
 
removal of salt and detergent. Care was taken for not allowing DNA to renature even briefly 
(i.e., by lowering pH below 12.3) until after electrophoresis, as this will result in DNA tangling 
and reduced migration. After these three rinses, slides were submerged in fresh A2 solution in an 
electrophoresis chamber. The chamber was filled with a consistent volume of buffer that is about 
1–2 mm above the top of the agarose. It was ensured that the chamber is level using a bubble 
leveling device. Electrophoresis was conducted in solution A2 for 25 min at a voltage of 0.6 
V/cm. The current was about 40 mA using 20 V.  
9.e. Slide Staining  
Slides were removed from electrophoresis chamber and were rinsed and neutralized in 400 ml of 
distilled water. Slides were placed in staining solution containing 2.5 μg/ml of propidium iodide 
in distilled water for 20 min. Finally the slides were rinsed with 400 ml distilled water to remove 
excess stain. 
9.f. Slide Analysis 
Analyzes of cells were done by examining at least 50 comet images from each   slide.  Analyzing 
doublets or comets at slide edges should be avoided. Image j analysis software was used to 
analyze individual comet images. 
 
10. Analysis of chromatin condensation by Hoechst 33342 staining: 
An average of 1×10
4 
cells were plated in 60mm petri plates. After 24 hours of seeding when cells 
get properly adhered to the plate surface, they were treated with sulforaphane and curcumin at 
their respective IC 50 values. The respective controls were left against each treated samples. After 
24 hours of drug treatment the cells were stained with Hoechst 33342 stain (1mg/ml) and  
incubated for 10 minutes at 37°C and images were taken under UV filter using Epi-fluorescent 
Microscope(Nikon TE 2000E).Condensed nucleus were counted against total number of nucleus 
in the field and the percentage of apoptotic nuclei were analyzed. 
 
11. DNA fragmentation assay: 
Fragmentation of DNA and chromatin is an integral process during apoptosis, and has been 
reported to occur in more than one distinct stage. During initial stages, high molecular weight 
DNA fragments of 50 kbp or longer size have been observed in morphologically normal cells 
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committed to undergo apoptosis. The low molecular weight DNA fragments are associated with 
late events such as formation of apoptotic bodies. The extensive nucleosome fragmentation or 
DNA fragmentation induced during apoptosis can be detected using techniques such as DNA 
ladder assay followed by agarose gel electrophoresis. For this purpose,2×10 
4 
cells were seeded 
in petriplates. The next day it was treated with 15µM of sulforaphane and 20 µM of curcumin 
and left for 24 hours of incubation in 5% CO2 incubator at 37°C.Then the next day cells were 
dislodged by trypsinization and washed with 1X PBS twice. 100µl of lysis buffer (1% NP-40 in 
20 mM EDTA, 50 mM Tris-HCl, and pH 7.5) was added and kept for 10 sec in order to lyse the 
cells.  For the Preparation of 1ml of  lysis buffer 10% NP-40 100 µl, 200 mM EDTA 100 µl , 0.2 
M Tris-HCl (pH 7.5) 250 µl , D.W. 550 µl were added together. After adding lysis buffer the 
solution was centrifuged at 3,000 rpm for 5 min to obtain the supernatant 10 µl of 10% SDS 
solution was added to pooled supernatant (final: 1% SDS), then it was treated with 10 µl of 50 
mg/ml RNase A (final 5 mg/ml) and incubated for 2 h at 56 C. After that 10 µl of 25 mg/ml 
Proteinase K (final 2.5 mg/ml) was added and again incubated for 2 h at 37 C. To this 1/2 vol. 
(65 µl) of 10 M ammonium acetate was added. 2.5 vol. (500 µl) of ice-cold ethanol was then 
added and mixed thoroughly and allowed to stand for 1 h in – 80 C freezer so that ethanol was 
precipitated. The solution was centrifuge for 20 min at 12,000 rpm, and then the white pellet was 
washed with 200 µl 80% ice cold ethanol and allowed to air-dry for 10 min at room temperature. 
The pellet was dissolved with 50 µl of TE buffer. DNA concentration was determined by taking 
absorbance at 260 and about 4 µg of the same concentration of DNA was run in 2% agarose gel 
electrophoresis. The gel picture was taken in a gel doc system. The densitometric calculations of 
the DNA bands were done using image j analysis software. 
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RESULT AND DISCUSSION 
 
1. Cell Viability assay by MTT method: 
 
The viability of MDA-MB-231 cell line, treated with Sulforaphane and Curcumin, was 
determined by analyzing the spectroscopic reading of MTT assay. The MTT assay was done for 
24,48and 72 hours of time period. The IC50 values for both the drugs were calculated against the 
cell viability percentage. The IC50 value of sulphoraphane was calculated at 15µM and curcumin 
at 25 µM concentration .The corresponding graphs are shown in graph-1 &2. 
 
 
Graph 1: MTT assay result of Sulforaphane (24, 48, 72 hours of treatment) 
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Graph 2: MTT assay result of Curcumin (24, 48, 72 hours of treatment) 
 
2. Isolation of Total Cellular RNA by Trizol method: 
The total cellular RNA was isolated following the manufacturer’s instruction with the help of 
Tri-reagent(Sigma).The isolation was carried out from the cultured MDA-MB-231 cells treated 
with sulforaphane and curcumin for 24 hours. The RNA was quantified with the help of Nano 
drop spectrophotometer. The 260/280 ratio and 260/230 ratio was measured to be in the range of 
1.8-2.0 and 2.0-2.2 respectively. The yield of RNA was good. The values of RNA yield, 260/280 
ratio,260/230 ratio are listed in the table-3 below. 
Table-3: Quantification of total cellular RNA 
Treatment Concentration(yield) 260/280 260/230 
Control 909.30µg/µl 1.90 1.98 
Sulforaphane 388 µg/µl 1.86 1.99 
Curcumin 617.00 µg/µl 2.01 2.05 
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3. Relative gene expression analysis by RT-PCR: 
From previous literature studies, it has been known that the anti apoptotic Bcl-2 is found to be up 
regulated and pro apoptotic Bax is down regulated in breast cancer cells. With our investigation 
we found that Sulphoraphane and curcumin treated MDA-MB-231 cells show a down regulation 
of anti apoptotic bcl-2 gene and an up regulation in pro apoptotic Bax gene expression. The 
status of Jmjd3 is also found to be down regulated with the treatment of sulforaphane and 
curcumin. The relative gene expression data is shown below in graph-3&4. 
 
Graph-3: Graphical representation of RT-PCR results for the expression of Bcl-2,Bax and 
Jmjd3 after treatment with sulforaphane. 
 
Graph-4: Graphical representation of RT-PCR results for the expression of Bcl-2, Bax and 
Jmjd3 after treatment with curcumin. 
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4. Analysis of Clonogenic assay for measuring cell survivability: 
Cells ability to divide and form colony as a measure of survivability potential can be measured 
by clonogenic assay. The MDA-MB-231 cells treated with sulforaphane and curcumin for 24 
hours showed reduced cell proliferation capacity as compared to the untreated samples. SFN 
treated samples showed more reduced number of colony formation. The pictures of the plates 
were taken and colonies were counted with the help of colony counting software. A graph was 
plotted taking the number of colonies formed with the treatment of sulforaphane and curcumin. 
The fig-6 below shows the clonogenic potential of MDA-MB-231 in response to drug treatment 
and the graph-5 shows quantification of clonogenic potential of MDA-MB-231 in response to 
sulforaphane and curcumin treatment. 
                           
Fig-6:Clonogenic potential of MDA-MB-231 cells in response to 24hrs treatment of 
sulforaphane and curcumin
 
Graph-5: Analysis of clonogenic assay of MDA-MB-231 cells with a 24 hours treatment of 
sulforaphane and curcumin. 
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5.Analysis of soft agar colony forming assay: 
Soft agar colony forming assay was done in an anchorage independent manner to know the 
survivability potential of MDA-MB-231 cells treated with sulforaphane and curcumin for 24 
hours .The colony forming ability was seen to be reduced in presence of sulforaphane and 
curcumin as compared to the control.The image of the soft agar colony and the graph showing 
number of colonies in presence of sulphoraphane and curcumin is shown below in fig-7 and 
graph-6. 
       
Fig-7:Soft agar colony forming assay of MDA-MB-231 cells in response to 24 hours of 
treatment with sulphoraphane and curcumin 
 
Graph-6: Analysis Soft agar colony forming assay of MDA-MB-231 cells in presence of 
sulphoraphane and curcumin 
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6. Analysis of chromatin condensation by Hoechst 33342 staining: 
After treatment of MDA-MB-231 cells with sulforaphane and curcumin for 24 hours, the plates 
were analyzed for any change in the morphology of nuclei. The formation of granulations in the 
nuclei is a measure of chromatin condensation which is well documented in the drug treated 
samples.  The result indicated that there were formations of more condensed chromatin after 
drug treatment. The images were taken and sown in the fig-8 below. 
 
Fig-8:Fluroscence microscopic image of condensed chromatin of MDA-MB-231 cells 
treated with sulforaphane and curcumin for 24 hours with respect to control. 
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7. DNA damage measured by Comet assay: 
MDA-MB-231 cells after treated with sulforaphane and curcumin were analyzed for DNA 
damage.The characteristic formtion of comet tail in drug treated cells confirmed that DNA 
damage occurred due to  the drug treatment,whereas the control showed the presence of a round 
head with no tail formation. Both curcumin and sulforaphanetreated cells were found to have 
prominent tail formation .The images of comet DNA were taken and analyzed with imagej 
software.The tail length, tail DNA percentage and tail moment were calculated with the help of 
software ang graphs were plottedwhich is shown below in graph-7,8,9 and the corresponding 
values are listed in the table-4. 
Table-4:Quantification of comet parameters(tail length,tail moment and tail DNA %) 
Drug Tail length(in pixels) Tail moment Tail DNApercentage 
Contro 45 5.936982331 13.19329407 
25 μM curcumin 130.4 21.32449134 16.35313753 
15 μM SFN 126.3 51.45276905 40.73853448 
 
Graph-7: Tail length of the comet formed due to the effect of sulforaphane and curcumin 
treatment for 24 hours  
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Graph-8: Tail DNA percentage in the comet formed due to the effect of sulforaphane and 
curcumin treatment for 24 hours  
 
Graph-9: Tail moment of the comet formed due to the effect of sulforaphane and curcumin 
treatment for 24 hours  
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8. Analysis of DNA fragmentation assay: 
The gel picture showed the fragmented DNA in case of sulphoraphane and curcumin treated 
MDA-MB-231 cells but in the untreated control cells, DNA remained intact near the lane. The 
fragmented DNA was visualized as separated bands.  Densitometric analysis of ladder lanes were 
done using Image-J software which showed distinct peaks representing a single band on the gel, 
ranging from high to low molecular weight. The gel picture and densitometric graph is shown in 
fig-9 and graph-10 respectively. 
 
Fig-9: Fragmented DNA ladders of MDA-MB-231 cells treated with sulforaphane and 
curcumin for 24 hours. 
 
Graph-10:Densitometric analysis of DNA fragmentation data 
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CONCLUSION 
Cancer progression is a bewildering combination of genetic and epigenetic alterations associated 
with principal cellular dysfunctions. The relentless proliferation potential and suppressed cell 
death mechanisms provide the underlying mechanisms of neoplastic progression. Hence 
researchers are now a day trying to target those deregulated pathways with the help of epigenetic 
modulatory drugs which are potent enough to drive the cancer cells towards programmed cell 
death from which they generally escape out. The balance between pro apoptotic and anti 
apoptotic gene expression is needed for the regulation of cell death mechanisms.  Additionally 
maintenance between methylation and demethylation patterns is tightly associated with cancer 
progression. Histone demethylase JMJD3 is having critical regulatory functions in cancer 
progression and its role in regulation of apoptosis is yet to be cleared. Here in this study, the 
down regulation of anti apoptotic gene Bcl-2 and up regulation of pro apoptotic gene Bax along 
with formation of chromatin condensation, DNA fragmentation and DNA damage suggests that 
there is induction of apoptosis in response to the sulphoraphane and curcumin treatment for 24 
hours at their corresponding IC50 values. From all this investigations we can presume that may be 
these natural polyphenols are mediating their effect on cancer cells at transcriptome level by 
inducing apoptosis related genes. Moreover the down regulation of Jmjd3 and down regulation 
of Bcl-2with treatment of sulphoraphane and curcumin may be correlated to have a conjoint 
effect on apoptosis induction in breast cancer cells. Further studies at protein level may unravel 
hidden dimensions of JMJD3 in the induction of apoptosis in breast cancer cells which may 
create a better therapeutic avenue for treating cancer patients in future. 
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